Marker Therapeutics, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold MRKR, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
8
Funds holding
$108850
Total value held
Buying
3 added/new · 0 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Northern Trust Corp | $50905 | 34629 | +8620 | +33.14% |
| 2 | State Street Corp | $30794 | 20948 | — | Held |
| 3 | Fifth Third Bancorp | $14700 | 10000 | — | Held |
| 4 | Ubs Group Ag | $11981 | 8150 | +8150 | NEW BUY |
| 5 | Wells Fargo & Company/Mn | $341 | 232 | — | Held |
| 6 | Barclays Plc | $93 | 63 | +63 | NEW BUY |
| 7 | Jpmorgan Chase & Co | $34 | 23 | — | Held |
| 8 | Morgan Stanley | $2 | 2 | — | Held |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.